Compound 741
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(F)c(c2)C(O)=O)c1=O
- InChi:
InChI=1S/C22H13F4N5O3/c1-30-19-14(9-27-30)18-16(17(28-19)10-3-2-4-11(7-10)22(24,25)26)20(32)31(29-18)12-5-6-15(23)13(8-12)21(33)34/h2-9,29H,1H3,(H,33,34)
- InChiKey:
SGCJAUAHBKBIMH-UHFFFAOYSA-N
External links
168318117 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.15 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 471.10 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 4.51 | |||
TPSA | 100.35 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4760 | Riociguat | DB08931 | |
0.4643 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4612 | Vericiguat | DB15456 | |
0.4569 | Risdiplam | DB15305 | |
0.4561 | ATX-914 | DB12673 | |
0.4515 | Decoglurant | DB11923 | |
0.4486 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4470 | Merestinib | DB12381 | |
0.4435 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4431 | Tepotinib | DB15133 | |
0.4390 | Dilmapimod | DB12140 | |
0.4344 | Ravoxertinib | DB15281 | |
0.4298 | MK-0249 | DB11910 | |
0.4280 | GSK-2636771 | DB11795 | |
0.4256 | (5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol | DB06983 |